These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 11845059)

  • 1. [Lansoprazole-associated collagenous colitis].
    Macaigne G; Boivin JF; Simon P; Chayette C; Cheaib S; Deplus R
    Gastroenterol Clin Biol; 2001 Nov; 25(11):1030. PubMed ID: 11845059
    [No Abstract]   [Full Text] [Related]  

  • 2. Lansoprazole-associated collagenous colitis: a case report.
    Rammer M; Kirchgatterer A; Höbling W; Knoflach P
    Z Gastroenterol; 2005 Jul; 43(7):657-60. PubMed ID: 16001348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagenous colitis associated with lansoprazole.
    Wilcox GM; Mattia A
    J Clin Gastroenterol; 2002 Feb; 34(2):164-6. PubMed ID: 11782613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [lymphocytic colitis associated with lansoprazole treatment].
    Ghilain JM; Schapira M; Maisin JM; De Maeght S; Piron A; Gerard R; Henrion J
    Gastroenterol Clin Biol; 2000 Oct; 24(10):960-2. PubMed ID: 11084433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lansoprazole-associated microscopic colitis: a case series.
    Thomson RD; Lestina LS; Bensen SP; Toor A; Maheshwari Y; Ratcliffe NR
    Am J Gastroenterol; 2002 Nov; 97(11):2908-13. PubMed ID: 12425567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is lansoprazole (Prevacid) or omeprazole (Prilosec) more effective in treating erosive esophagitis?
    Kim JD
    J Fam Pract; 2002 Apr; 51(4):384. PubMed ID: 11978268
    [No Abstract]   [Full Text] [Related]  

  • 7. Linear mucosal defects: a characteristic endoscopic finding of lansoprazole-associated collagenous colitis.
    Nomura E; Kagaya H; Uchimi K; Noguchi T; Suzuki S; Suzuki M; Onodera H; Tateno H
    Endoscopy; 2010; 42 Suppl 2():E9-10. PubMed ID: 20066608
    [No Abstract]   [Full Text] [Related]  

  • 8. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis.
    Umeno J; Matsumoto T; Nakamura S; Jo Y; Yada S; Hirakawa K; Yoshimura R; Yamagata H; Kudo T; Hirano A; Gushima M; Yao T; Nakashima Y; Iida M
    Gastrointest Endosc; 2008 Jun; 67(7):1185-91. PubMed ID: 18513560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diarrhea associated with lansoprazole.
    Mukherjee S
    J Gastroenterol Hepatol; 2003 May; 18(5):602-3. PubMed ID: 12702056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients.
    Giral A; Celikel CA; Ozdogan O; Tözün N; Ulusoy NB; Kalayci C
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1886-91. PubMed ID: 16336449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microscopic colitis associated with exposure to lansoprazole.
    Hilmer SN; Heap TR; Eckstein RP; Lauer CS; Shenfield GM
    Med J Aust; 2006 Feb; 184(4):185-6. PubMed ID: 16489905
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropathy associated with lansoprazole treatment.
    Rajabally YA; Jacob S
    Muscle Nerve; 2005 Jan; 31(1):124-5. PubMed ID: 15468341
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of patients with heartburn without endoscopic evaluation: on-demand treatment after effective continuous administration of lansoprazole 15 mg.
    Bigard MA; Genestin E
    Aliment Pharmacol Ther; 2005 Oct; 22(7):635-43. PubMed ID: 16181303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In support of "step-up therapy" for gastroesophageal reflux disease.
    Beck IT
    Am J Gastroenterol; 2002 Feb; 97(2):503-4. PubMed ID: 11866309
    [No Abstract]   [Full Text] [Related]  

  • 15. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K; Hashimoto T; Komazawa Y; Mihara T; Furuta K; Fujishiro H; Ishihara S; Amano Y; Hattori S; Kinoshita Y
    Dig Liver Dis; 2005 Jul; 37(7):485-90. PubMed ID: 15975534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain--a randomized, double-blind, placebo-controlled, crossover trial.
    Bautista J; Fullerton H; Briseno M; Cui H; Fass R
    Aliment Pharmacol Ther; 2004 May; 19(10):1123-30. PubMed ID: 15142202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased microvascular permeability in early stage of dextran sulfate sodium-induced colitis: its interaction with lansoprazole binding sites.
    Nakamura M; Asada M; Matsui H; Hibi N; Tsuchimoto K; Inoue J; Oda M
    Clin Hemorheol Microcirc; 2006; 34(1-2):193-9. PubMed ID: 16543636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lansoprazole-induced hyponatremia].
    Fort E; Laurin C; Baroudi A; Liebaert-Bories MP; Strock P
    Gastroenterol Clin Biol; 2000; 24(6-7):686. PubMed ID: 10962399
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
    Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
    Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against aspiration with the Proseal laryngeal mask airway.
    de Silva KK; Young P
    Anaesth Intensive Care; 2002 Jun; 30(3):391. PubMed ID: 12075662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.